NZBIO Conference 2010 - New Zealand's Premier Bio Event
Advancing a Biobased economy. 21-24 March. Auckland, New Zealand
Investor & Technology Showcase
The NZBIO 2010 Draft Investor & Technology Showcase Programme is now available!
NZBIO is delighted to have the following Investors attend the Investors Showcase
New Zealand Venture Investment Fund
Trans-Tasman Commercialisation Fund
13:00
Meet the Investors
Nick Peace, Investment Director, Starfish Ventures
Paul D'Sylva, Venture Partner, Ample Luck Securities
Brent Ogilvie, Director, Pacific Channel
Chair: Maxine Simmons, Director, BioCatalyst
14:30
"Innate Therapeutics Immune Modulating Microparticle - a Second Generation Approach to Immune Modulation"
Peter Bradley, Chief Business Development Officer, Innate Therapeutics
14:30
"Science Provider, Regulator, Stake Holder - Win, Win, Win for Aquaculture"
Paul McNabb, Technical Manager, Cawthron Institute
14:30
"Personalised Modelling for Risk of Disease & Clinical Outcome Prognosis"
Prof Nikola Kasabov, Director & Founder of KEDRI, Auckland University of Technology
14:30
"Future Human Central Nervous System Therapies will be Dominated by Highly Potent and Efficacious Drugs"
Frank Sieg, Chief Scientific Officer, Curonz
16:30
Novel Therapies, Lead Identification & Drug Delivery
"Discovery to Drug, The Commercialisation Challenges" Judy Halliday, Commercialisation Manager, Life Sciences, UniQuest
"Molecules, Mice, to Men: Translation of Targeted Therapeutics for Advanced Prostate Cancer" Prof Colleen Nelson, Executive Director Australian Prostate Cancer Research Centre, Queensland University of Technology
"Cell Therapy Product Development: A Regulatory Perspective"
Dr Dianne Jackson-Matthews, Deputy Group Director of Regulatory Affairs, ERA Consulting
"Nanotechnology-Based Anticancer Drug Delivery Systems" Associate Professor Sanjay Garg, Chief Scientific Officer, AnQual GLP Laboratories
Chair: Prof Peter Shepherd, Professor of Cellular Signalling, University of Auckland
